These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 27475884)

  • 1. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis.
    Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E
    Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment.
    Rosa AC; Pini A; Lucarini L; Lanzi C; Veglia E; Thurmond RL; Stark H; Masini E
    J Pharmacol Exp Ther; 2014 Nov; 351(2):308-16. PubMed ID: 25185215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines.
    Cowden JM; Riley JP; Ma JY; Thurmond RL; Dunford PJ
    Respir Res; 2010 Jun; 11(1):86. PubMed ID: 20573261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of PARP-1 Deficiency and Histamine H
    Durante M; Sgambellone S; Lanzi C; Nardini P; Pini A; Moroni F; Masini E; Lucarini L
    Front Pharmacol; 2019; 10():525. PubMed ID: 31164820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
    Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
    Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
    Pini A; Viappiani S; Bolla M; Masini E; Bani D
    J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.
    Lucarini L; Durante M; Lanzi C; Pini A; Boccalini G; Calosi L; Moroni F; Masini E; Mannaioni G
    J Cell Mol Med; 2017 Feb; 21(2):324-335. PubMed ID: 27704718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of functionally different histamine H
    Adami M; Micheloni C; Grandi D; Stark H
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1387-1397. PubMed ID: 30145688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
    Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
    Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS.
    Gungor H; Ekici M; Onder Karayigit M; Turgut NH; Kara H; Arslanbas E
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1659-1670. PubMed ID: 32377772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.
    Zhang C; Cai R; Lazerson A; Delcroix G; Wangpaichitr M; Mirsaeidi M; Griswold AJ; Schally AV; Jackson RM
    Lung; 2019 Oct; 197(5):541-549. PubMed ID: 31392398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
    Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
    Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia.
    Kseibati MO; Sharawy MH; Salem HA
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107011. PubMed ID: 33045575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of histamine H
    Sgambellone S; Febo M; Durante M; Marri S; Villano S; Bereshchenko O; Migliorati G; Masini E; Riccardi C; Bruscoli S; Lucarini L
    Inflamm Res; 2023 Nov; 72(10-11):2037-2052. PubMed ID: 37815550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic inflammation is augmented via histamine H4 receptor activation: The role of natural killer cells in vitro and in vivo.
    Ehling S; Roßbach K; Dunston SM; Stark H; Bäumer W
    J Dermatol Sci; 2016 Aug; 83(2):106-15. PubMed ID: 27155791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
    Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
    Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
    Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
    J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.